NY-ESO-1 specific antibodies are frequently detected in hight-risk myeloma.

被引：0
|
作者：
van Rhee, F
Szmania, SM
Pomtree, M
Zhan, F
Moreno, A
Rosen, N
Fox, M
Barlogie, B
Shaughnessy, J
Batchu, R
Tricot, GJ
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2464
引用
收藏
页码：676A / 676A
页数：1
相关论文
共 50 条
  • [41] Genetically engineered NY-ESO-1 specific T cells in HLA-A201+patients with advanced cancers.
    Merchant, Melinda S.
    Cristea, Mihaela C.
    Stadtmauer, Edward A.
    Tap, William D.
    D'Angelo, Sandra P.
    Grupp, Stephan A.
    Holdich, Tom
    Binder-Scholl, Gwendolyn
    Jakobsen, Bent K.
    Odunsi, Kunle
    Rapoport, Aaron
    Mackall, Crystal
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
    Oshima, Yoko
    Shimada, Hideaki
    Yajima, Satoshi
    Nanami, Tatsuki
    Matsushita, Kazuyuki
    Nomura, Fumio
    Kainuma, Osamu
    Takiguchi, Nobuhiro
    Soda, Hiroaki
    Ueda, Takeshi
    Iizasa, Toshihiko
    Yamamoto, Naoto
    Yamamoto, Hiroshi
    Nagata, Matsuo
    Yokoi, Sana
    Tagawa, Masatoshi
    Ohtsuka, Seiko
    Kuwajima, Akiko
    Murakami, Akihiro
    Kaneko, Hironori
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (01) : 30 - 34
  • [43] NY-ESO-1 Is a Sensitive and Specific Marker for Myxoid and Round Cell Liposarcomas among Other Mesenchymal Myxoid Neoplasms
    Hemminger, J. A.
    Toland, A. E.
    Iwenofu, O. H.
    MODERN PATHOLOGY, 2013, 26 : 13A - 13A
  • [44] Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population
    Ohkuri, Takayuki
    Sato, Masayoshi
    Abe, Hiroyuki
    Tsuji, Keiko
    Yamagishi, Yuka
    Ikeda, Hiroaki
    Matsubara, Naoki
    Kitamura, Hidemitsu
    Nishimura, Takashi
    CANCER SCIENCE, 2007, 98 (07) : 1092 - 1098
  • [45] Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
    Tim Luetkens
    Sebastian Kobold
    Yanran Cao
    Marina Ristic
    Georgia Schilling
    Sinje Tams
    Britta Marlen Bartels
    Julia Templin
    Katrin Bartels
    York Hildebrandt
    Sara Yousef
    Andreas Marx
    Friedrich Haag
    Carsten Bokemeyer
    Nicolaus Kröger
    Djordje Atanackovic
    Cancer Immunology, Immunotherapy, 2014, 63 : 1151 - 1162
  • [46] Immune Responses Detected in Urothelial Carcinoma Patients After Vaccination With NY-ESO-1 Protein Plus BCG and GM-CSF
    Sharma, Padmanee
    Bajorin, Dean F.
    Jungbluth, Achim A.
    Herr, Harry
    Old, Lloyd J.
    Gnjatic, Sacha
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 849 - 857
  • [47] Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma
    Stadtmauer, Edward A.
    Faitg, Thomas H.
    Lowther, Daniel E.
    Badros, Ashraf Z.
    Chagin, Karen
    Dengel, Karen
    Iyengar, Malini
    Melchiori, Luca
    Navenot, Jean-Marc
    Norry, Elliot
    Trivedi, Trupti
    Wang, Ruoxi
    Binder, Gwendolyn K.
    Amado, Rafael
    Rapoport, Aaron P.
    BLOOD ADVANCES, 2019, 3 (13) : 2022 - 2034
  • [48] Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
    Luetkens, Tim
    Kobold, Sebastian
    Cao, Yanran
    Ristic, Marina
    Schilling, Georgia
    Tams, Sinje
    Bartels, Britta Marlen
    Templin, Julia
    Bartels, Katrin
    Hildebrandt, York
    Yousef, Sara
    Marx, Andreas
    Haag, Friedrich
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    Atanackovic, Djordje
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (11) : 1151 - 1162
  • [49] Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1 c259t. in HLA-A2+ patients with synovial sarcoma (NCT01343043).
    Mackall, Crystal
    Tap, William D.
    Glod, John
    Druta, Mihaela
    Chow, Warren Allen
    Araujo, Dejka M.
    Grupp, Stephan A.
    Van Tine, Brian Andrew
    Chagin, Karen
    Van Winkle, Erin
    Kari, Gabor
    Trivedi, Trupti
    Norry, Elliot
    Holdich, Tom
    Bartlett-Pandite, Arundathy N.
    Amado, Rafael G.
    D'Angelo, Sandra P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms
    Hemminger, Jessica A.
    Iwenofu, O. Hans
    MODERN PATHOLOGY, 2013, 26 (09) : 1204 - 1210
12345